These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38809626)

  • 1. Comprehensive Analysis of the Expression, Prognosis, and Immune Infiltrates for Chromodomain-Helicase-DNA-Binding Proteins in Breast Tumor.
    Hasanlu M; Amiri-Dashatan N; Farahani M; Koushki M; Ahmadi H; Parsamanesh N; Ahmadi NA
    Asian Pac J Cancer Prev; 2024 May; 25(5):1547-1558. PubMed ID: 38809626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer.
    Li D; Zhao W; Zhang X; Lv H; Li C; Sun L
    Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of chromodomain helicase DNA-binding protein 9 is a novel independent prognostic biomarker for colorectal cancer.
    Xu L; Peng H; Huang XX; Xia YB; Hu KF; Zhang ZM
    Braz J Med Biol Res; 2018 Jul; 51(9):e7588. PubMed ID: 30043858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACE2 maybe serve as a prognostic biomarker in breast invasive carcinoma.
    Ling J; Peng N; Luo L
    J Clin Lab Anal; 2022 Jun; 36(6):e24362. PubMed ID: 35373393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of eIF4E is associated with tumor macrophage infiltration and leads to poor prognosis in breast cancer.
    Li F; Sun H; Li Y; Bai X; Dong X; Zhao N; Meng J; Sun B; Zhang D
    BMC Cancer; 2021 Dec; 21(1):1305. PubMed ID: 34876062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotranscriptomic meta-analysis of the CHD family chromatin remodelers in human cancers - initial evidence of an oncogenic role for CHD7.
    Chu X; Guo X; Jiang Y; Yu H; Liu L; Shan W; Yang ZQ
    Mol Oncol; 2017 Oct; 11(10):1348-1360. PubMed ID: 28649742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic analysis of the expression and prognostic value of ITPR1 and correlation with tumor infiltrating immune cells in breast cancer.
    Han B; Zhen F; Zheng XS; Hu J; Chen XS
    BMC Cancer; 2022 Mar; 22(1):297. PubMed ID: 35313846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and expressional alterations of CHD genes in gastric and colorectal cancers.
    Kim MS; Chung NG; Kang MR; Yoo NJ; Lee SH
    Histopathology; 2011 Apr; 58(5):660-8. PubMed ID: 21447119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of the expression, prognosis, and immune infiltrates for CHDs in human lung cancer.
    Lv Y; Lin W
    Discov Oncol; 2022 Apr; 13(1):29. PubMed ID: 35467222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceruloplasmin correlates with immune infiltration and serves as a prognostic biomarker in breast cancer.
    Chen F; Han B; Meng Y; Han Y; Liu B; Zhang B; Chang Y; Cao P; Fan Y; Tan K
    Aging (Albany NY); 2021 Aug; 13(16):20438-20467. PubMed ID: 34413268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat Shock Protein 90 Family Isoforms as Prognostic Biomarkers and Their Correlations with Immune Infiltration in Breast Cancer.
    Lin T; Qiu Y; Peng W; Peng L
    Biomed Res Int; 2020; 2020():2148253. PubMed ID: 33145341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromodomain 4 is a potent prognostic marker associated with immune cell infiltration in breast cancer.
    Zhong L; Yang Z; Lei D; Li L; Song S; Cao D; Liu Y
    Basic Clin Pharmacol Toxicol; 2021 Jan; 128(1):169-182. PubMed ID: 32799413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of CHD1L over-expression is associated with aggressive tumor biology and is a novel prognostic biomarker for patient survival in human breast cancer.
    Wu J; Zong Y; Fei X; Chen X; Huang O; He J; Chen W; Li Y; Shen K; Zhu L
    PLoS One; 2014; 9(8):e98673. PubMed ID: 25153161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of LCN1 as a Potential Biomarker for Breast Cancer by Bioinformatic Analysis.
    Yang Y; Li F; Luo X; Jia B; Zhao X; Liu B; Gao R; Yang L; Wei W; He J
    DNA Cell Biol; 2019 Oct; 38(10):1088-1099. PubMed ID: 31424267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PCMT1 Is a Potential Prognostic Biomarker and Is Correlated with Immune Infiltrates in Breast Cancer.
    Guo J; Du X; Li C
    Biomed Res Int; 2022; 2022():4434887. PubMed ID: 35535040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of the expression, prognostic significance, and regulation pathway of G2E3 in breast cancer.
    Shen Y; Xue J; Yu J; Jiang Y; Bu J; Zhu T; Gu X; Zhu X
    World J Surg Oncol; 2022 Dec; 20(1):398. PubMed ID: 36517818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Analysis of the Prognostic Marker and Immune Infiltrates of LDLR-Related Proteins Family Members in Breast Cancer.
    Shahidi S; Ansari Shayesteh P; Alami M; Parsamanesh N
    Iran J Pathol; 2024; 19(1):31-49. PubMed ID: 38864077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative analysis of prognostic value and immune infiltration of spindle and kinetochore-associated family members in breast cancer.
    Ding J; He X; Wang J; Cao G; Chen S; Yuan L; Chen B; Xiong M
    Bioengineered; 2021 Dec; 12(2):10905-10923. PubMed ID: 34845974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TIMM8A is associated with dysfunction of immune cell in BRCA and UCEC for predicting anti-PD-L1 therapy efficacy.
    Zhu X; Yuan Z; Cheng S; Wang H; Liao Y; Zhou D; Wu Z
    World J Surg Oncol; 2022 Oct; 20(1):336. PubMed ID: 36207751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Role of hsa-mir-124 in Predicting Clinical Outcome in Breast Invasive Carcinoma Based on Bioinformatics Analysis.
    Feng T; Zhang P; Sun Y; Han X; Tong J; Hua Z
    Biomed Res Int; 2020; 2020():1839205. PubMed ID: 32190652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.